# CMC Pharmaceuticals, Inc.

Canonical: https://abierto.us/vendors/cmc-pharmaceuticals-inc-r9avs7xl2yb4

- UEI: R9AVS7XL2YB4
- CAGE: 7UJR5
- Location: Solon, OH
- Awards in window: 1 (1 transactions), $431,622 obligated, May 15, 2024 to May 15, 2024

## Awarding agencies

- Department of the Army: 1 awards, $431,622

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $431,622

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- W911SR23C0019 (definitive contract): $431,622, W6QK ACC-APG. Modification P00002 Exercises Optional Contract Line Item 0002 for Continued Research of Pharmaceutical Development, Planning, and Cmo Identification for the Expedited Advancement of a Scopolamine Multi-Dose-Vial Drug Product.. https://www.usaspending.gov/award/CONT_AWD_W911SR23C0019_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cmc-pharmaceuticals-inc-r9avs7xl2yb4.